What is NDC 43598-339?

43598-339 is the product NDC for Aspirin and Dipyridamole, Aspirin 25 mg/1; Dipyridamole 200 mg/1 capsule, extended release, listed with the FDA by Dr. Reddy's Laboratories Inc. It has 1 package NDC, shown above in 10- and 11-digit form.

Dr. Reddy's Laboratories Inc, NDC labeler code 43598. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Aspirin and Dipyridamole?

1 other product NDC are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Aspirin and Dipyridamole NDC 43598-339

NDC codes

FDA NDC Directory

Product NDC (as listed)43598-339Labeler and product segments. Claims need a package NDC.

Product NDC at billing width43598-0339Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
43598-339-60	4359803396043598033960	60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (43598-339-60)Marketed from Oct 10, 2018

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Aspirin and Dipyridamole
Generic name (nonproprietary): aspirin and dipyridamole
Active ingredients: Aspirin — 25 mg/1Dipyridamole — 200 mg/1
Dosage form: Capsule, Extended release
Route: Oral
Labeler: Dr. Reddy's Laboratories IncNDC labeler code 43598
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 209048
Marketing start: Oct 10, 2018
Listing expires: Dec 31, 2027
Other FDA classes: Non-Steroidal (Chemical structure)Cyclooxygenase Inhibitors (Mechanism)Decreased Platelet Aggregation (Physiologic effect)Decreased Platelet Aggregation (Physiologic effect)Decreased Prostaglandin Production (Physiologic effect)
Identifiers: Product ID 43598-339_4483f2db-5250-45fd-e1b1-03ffa74a4eb1SPL ID 4483f2db-5250-45fd-e1b1-03ffa74a4eb1SPL set ID 92222dd3-7802-2a03-7d30-58cf192cc33eRxCUI 259081UNII R16CO5Y76E, 64ALC7F90CUPC 0343598339603
Pharmacologic class: Nonsteroidal Anti-inflammatory Drug; Platelet Aggregation Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N443598033960 followed by a unit qualifier and the quantity

Package 43598-0339-60. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 31, 2021.

Indications (excerpt from the label)

Aspirin and extended-release dipyridamole capsules are indicated to reduce the risk of stroke in patients who have had transient ischemia of the brain or completed ischemic stroke due to thrombosis. Aspirin and extended-release dipyridamole capsules are a combination of aspirin and dipyridamole, antiplatelet agents, indicated to reduce the risk of stroke in patients who have had transient ischemia of the brain or completed ischemic stroke due to thrombosis ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 43598-339

What is NDC 43598-339?: 43598-339 is the product NDC for Aspirin and Dipyridamole, Aspirin 25 mg/1; Dipyridamole 200 mg/1 capsule, extended release, listed with the FDA by Dr. Reddy's Laboratories Inc. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Aspirin and Dipyridamole.
What is the active ingredient?: Aspirin, Dipyridamole.
Who is the labeler?: Dr. Reddy's Laboratories Inc, NDC labeler code 43598. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Aspirin and Dipyridamole?: 1 other product NDC are listed under this name. See all Aspirin and Dipyridamole NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Aspirin and Dipyridamole NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Aspirin and Dipyridamole	Aspirin 25 mg/1; Dipyridamole 200 mg/1	Capsule, Extended releaseOral	NorthStar Rx LLC	16714-964	16714-0964-01

Other NDCs under ANDA 209048

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 209048
Product	Strength	Form · route	Labeler	Product NDC
Aspirin and Dipyridamole	Aspirin 25 mg/1; Dipyridamole 200 mg/1	Capsule, Extended releaseOral	NorthStar Rx LLC	16714-964